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Curcumin (CUR), the main phenolic composition in turmeric, shows preventive effects in
various diseases. CUR is commonly found in the Curcuma species and historically
applied in herbal medicine. Numerous studies have indicated that CUR possesses pro-
tective effects against toxic agents in the various animal tissues including the brain. This
study found that CUR may be effective in nervous system problems induced by neuro-
toxic agents. However, due to the lack of information on human, more investigations are
needed to determine the efﬁcacy of CUR as an antidote matter. The current study aimed
to critically review the recent literature data from 2014 to 2016 that regarding the ther-
apeutic aspects of CUR versus neurotoxic agents-induced brain damage and its involved
mechanisms.1. Introduction
1.1. General knowledge
Flavonoids are the main compound of plant's ingredients
with extensive vital abilities selected for treatment of diseases
[1,2]. The investigation on ﬂavonoids has been continuing with
developing concern as they do by a lot of signaling lines
interfered in different medical disorders [3]. Flavonoids are
also the main polyphenolic ingredients that express a variety
of biological activities, such as anti-microbial, anti-inﬂamma-
tory, anti-thrombotic, antioxidant, anti-allergic, anti-microbial,
analgesic, and vasodilatory effects [4].
Curcumin (diferuloylmethane) (CUR), famous ﬂavonoids,
with the chemical formula of 1,7-bis(4-hydroxy-3 methox-
yphenyl)-1,6-heptadiene-3,5-dione, has been separated from the
ground rhizome of the Curcuma species [5]. Curcumae longae,
prevalently named as turmeric, is connected with theZingiberaceae's family and a native of south and southeastern
Asia, particularly India [6]. Turmeric is usually applied as a
ﬂavoring, natural yellow agent, perfume ingredient and food
additive [7]. The prominent chemical ingredient of turmeric is
a polyphenolic ingredient named curcuminoids, including
bisdemethoxycurcumin, demethoxycurcumin, and CUR [8].
Curcuminoids were ﬁrst studied by Vogel and Pelletier, and
indicated to be diferuloylmethane (C21H20O6) in 1910 [8,9].
Among the three components, CUR as a most active
component of turmeric has the highest concentration in the
total spice [9]. Turmeric and its ingredients have been applied
in historical medicine for treatment of several disorders and
current physiological studies have been investigating its
fruitful effects [10]. According to the cultured cells, animal
models, and human clinical trials ﬁndings, turmeric and CUR
may be effective treatment for immunosystem disorders [11],
neurodegenerative disorders [12], coronary artery diseases [13],
respiratory failures [14], gastrointestinal diseases [15], urinary
system failures [16], parasitic infections [17], joint pain,
inﬂammation [18], and dental problems [19]. Turmeric and its
main ingredients have also been elucidated to control
anticancer [20] anti-microbial [21], and anti-genotoxic effects
[22]. The health effects of turmeric may stem from its main
ingredients such as CUR. The antioxidant, anti-apoptotic, anti-
inﬂammatory and immunomodulatory activity of CUR lead to
the control of reverse destructive processes [23].the CC BY-NC-ND license (http://
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effects and diseases management against toxic agents-induced
toxicity through various mechanisms [24]. The neuroprotective
effect of CUR has been reported to have the effects against some
toxic materials [24]. However, different from the ﬂavonoids, the
fruitful effects of CUR in the act of toxin materials remain
nascent in current literature. Therefore, this review aimed to
provide an updated overview of studies on the therapeutic aspect
of CUR versus neurotoxicity produced by neurotoxic agents.
1.2. Chemistry and structural characterization of CUR
CUR [(1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-
heptadiene-3,5-dione or diferuloylmethane, 1] (Figure 1) belongs
to a class of chemicals called ﬂavonoids which induces turmeric's
yellow color [25]. Turmeric consists of 2–5% CUR. For the ﬁrst
time, CUR was puriﬁed from turmeric, and the chemical formula
was found as diferuloylmethane [25]. Recent study shows that
CUR's samples include nearly 4% bisdemethoxycurcumin, 20%
demethoxycurcumin, and 76% diferuloylmethane [26]. According
to these structures, CUR has a seven carbon linker and three
major functional groups including an alpha, beta-unsaturated
beta-diketone moiety and an aromatic o-methoxy phenolic group
[26]. The antioxidant activity of CUR is related to the o-
methoxyphenol group and methylenic hydrogen and it also
contributes an electron/hydrogen atom to free radicals. The
alpha, beta-unsaturated beta-diketone moiety strongly via
Michael reaction acts with protein thiols [26]. CUR acts as a
chelator of heavy metals via interaction of beta-diketo group
with transition metals, thereby decreasing metal toxicity [27]. CUR
is a hydrophobic compound and mostly dissolvable in acetone,
oils, ethanol, and, dimethylsulfoxide. In acidic condition, the dye
of turmeric/CUR changes from amber to dark red [26]. Among
three analogs, CUR exhibits most potent activity in some
systems [28]. CUR is metabolized into curcumin sulfonate and
curcumin glucuronide after orally prescription and metabolized
into hexahydrocurcuminol, tetrahydrocurcumin (THC), and
hexahydrocurcumin after i.p. injection [28]. THC has been
activated in some circumstance; however, the biological activity
of CUR is not known [28].
1.3. Safety study of CUR
Safety of CUR has been indicated for many years; however, its
innocuousness is not clear as pharmaceutical formulations at high
doses in the dietary matrix. Animal studies indicated safety of this
compound. USNational Cancer Institute (NCI) indicated that CUR
administration in monkeys, dogs, and rats at doses of up to 3.5 g/kg
for up to 3 months has not any adverse effects [29]. Various studies
indicated that dietary CUR administration at 2% of the diet in rats
and mice has no toxicity. Human studies also conﬁrmed that
dietary administration of turmeric (1.5 g/d, equating to 150 mg/
d), was safe for human [30]. Administration of 0.55 g and 1.65 gFigure 1. Chemical structure of curcumin.CUR per day to person with inﬂammatory bowel for 28 d had no
any adverse effects [31]. Patients with rheumatoid arthritis who
received 1.2–2.1 g of oral CUR daily for 2–6 weeks had no
clinical manifestations of toxicity [32]. Adverse effects were not
seen in patients with high-risk premalignant conditions or pre-
invasive malignant that received 8 g of oral CUR per day for 3
months [33]. Cheng et al. 2001 indicated that oral administration of a
dose of CUR from500 to 8000mg/d for 3months had not any toxic
effect in patients with Bowens disease, oral leukoplakia, resected
bladder cancer, stomach metaplasian, and cervical intraepithelial
neoplasm (CIN) [33]. Toxicity was not observed in patients with
advanced colorectal cancer that used a dose of 440–2200 mg/
d extract of Curcuma, equivalent to 36–180 mg CUR, for up to 4
months [34]. Until one month of treatment, neither CUR nor its
metabolites were found in the urine and plasma but both
curcumin sulfate and CUR were observed in feces. Toxicity was
not found after administration of CUR ranging from 500 to
12000 mg in healthy human volunteers [35]. Low concentrations
of CUR were observed only in the serum of patient that
consumed 10000 or 12000 mg/d of CUR [36]. Even histological
examination showed that CUR treatment improved precancerous
lesions in some cases, including two patients with intestinal
metaplasia of the stomach, 2 patients with Bowens disease, one
patient with bladder cancer, and one patient with CIN could be
promoted into a drug for the treatment and prevention of
disorders including cancer. Because of its weak bioavailability,
oral consumption of CUR at low levels are not performed outside
the gastrointestinal tract [35]. Therefore, the oral consumption of
CUR does not cause cytotoxic concentrations outside the
gastrointestinal tract. However, few studies indicated adverse
effects of CUR and curcuminoids in some situation. In vivo study
indicated that CUR acted as an iron chelator and induced iron
deﬁciency anemia in mice fed with diets poor in iron [37].
This proposes that CUR deteriorates iron metabolism, especially
in people with iron deﬁciency. CUR has also been found
to disturb the activity of the drug-metabolizing enzymes
including glutathione-S-transferase, cytochrome P450, and UDP-
glucuronosyltransferase [37]. The inhibition of these enzymes may
increase the plasma levels of some chemicals and it may causes
toxicity [37]. These toxic effects of CUR may be also induced by
reactive oxygen species (ROS) [38]. Animal experiments have
indicated that, despite the fact that a low concentration of CUR
has antioxidant effects, higher levels of CUR induce the ROS
levels [38]. The low clinical efﬁciency of CUR treatment in the
cancer diseases has been discussed recently [39]. However, the
some adverse effects were observed in patient with cancer. In this
context, developed diarrhea was observed in patients with
developed gastrointestinal cancer, after CUR treatment for up to 4
months [39]. According to the present preclinical data, CUR
administration should be prescribed cautiously in patients with
certain conditions [39]. However, the concentration of CUR
applied in different investigations is not clear due to its various
content in the various type of turmeric [39]. Although there is
study concentrated on the adverse effects of CUR, it is signiﬁcant
to have a document indicating that CUR has therapeutical effects
and acts as an antidote agent against toxic materials [39].
2. Methods
Online papers were considered through various search web-
sites including PubMed, Iran Medex, Medline, Google Scholar,
and Scopus from 2014 to 2016 to ﬁnd reviews, editorials, and
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3. Protective effects of CUR against agents-induced
neurotoxicity
3.1. D-galactosamine
D-galactose (GalN), causes oxidative stress leading to the
damage to hippocampal neurons, modiﬁcation in mitochondrial
function, and reduction in protein content; hence, it is used to
induce pathways involved in aging processes in animal models
[40]. CUR contribution in preventing GalN induced aging has
been reported. It was observed that oral administration of
CUR (50 mg/kg and 100 mg/kg) for 63 d improved the
cognitive defect induced by GalN in rats. It was suggested
that CUR improved GalN induced neurotoxicity by decreasing
lipid peroxidation, protein oxidation (PO), and cleaved
caspase-3 (CASP3) expression, as well as increasing antioxi-
dant content in the neuronal mitochondria [36].
3.2. Fluoride (F)
F, the major inorganic ion, is well-recognized as a global
problem that causes various diseases such as neurological fail-
ures and F-induced neurological diseases by disrupting neuronal
cell bodies in selective brain areas [41]. F may penetrate into the
brain, gather in hippocampus and induce process involved in the
oxidative stress pathways [41]. The possible therapeutic aspects
of CUR versus F-induced oxidative stress in hippocampal
regions of mice have been reported. It was indicated that co-
treatment of CUR (30 mg/kg) with F (120 ppm) for 30 d
resulted in severe decreases in lipid peroxidation with a reduc-
tion in neurodegeneration in adult mice [42].
3.3. Formaldehyde (FA)
Formaldehyde is an aldehyde compound with highly toxic
property for human and all animals [43]. FA induces cellular
DNA damage via rising the generation of ROS. It was seen
that CUR (100 mg/kg) treatment for 15 d improved oxidative
stress induced by FA in rat brain [43].
3.4. Rotenone (ROT)
ROT, crystalline isoﬂavone, used as an insecticide and pesticide
that is mildly toxic to human and other animals [44]. It has reported
that ROT injection into rats caused the development of signs
resembling to those of Parkinson's disease (PD) [44]. PD is a
disease in brain related to age that is connected with 70% of
substantia nigra's neurons that release dopamine [44]. Oxidative
damage and mitochondrial disorders are involved in the
pathogenesis of PD. CUR has been showed to act as a
neuroprotective on an animal model for induction of PD [44]. It
was indicated that CUR ameliorated tyrosine hydroxylase (TH)
and motor dysfunction levels in the substantia nigra of ROT-
injured rats [44]. In addition, CUR decreased ROS and
malondialdehyde (MDA) levels and also raised glutathione
(GSH) content. Indeed, CUR ameliorated ROT-induced damage,
through nuclear factor erythroid 2-related factor 2 (Nrf2) and the
phosphorylation of Akt [44]. This study proposed that CURameliorated ROT-induced oxidative damage to the dopaminergic
neurons in the Snap of animals through the Act/Nrf2 pathway [44].
3.5. Vincristine (VCR)
VCR is used as a chemotherapy agent to treat a number of
types of cancer [45]. VCR may induce peripheral neuropathy
through oxidative stress and inﬂammation in neurons and lead
to discontinuation of chemotherapy [45]. The therapeutic effect
of THC 40 mg/kg and 80 mg/kg against VCR induced
neuropathy in animals has been observed. Hot plate, Randall–
Selitto test, cold plate (thermal) test, formalin test and
nociception indicated the preventive effect of THC in rats that
received VCR. Total calcium, lipid peroxidation, nitric oxide
(NO) and TNF-a levels in sciatic nerve tissue homogenate was
improved in THC (80 mg/kg) treated group versus non-treated
rats that received VCR. In addition, GSH activity and the levels
of catalase (CAT), glutathione peroxidase (GPx), and superoxide
dismutase (SOD) increased in treated rats. Histopathological
assessment on sciatic nerve also conﬁrmed the therapeutic effect
of THC versus the VCR. The neuroprotective effects of THC
(80 mg/kg) may be on account of anti-inﬂammatory, anti-noci-
ceptive, antioxidant and calcium inhibitory effects [46].
3.6. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
(MPTP)
MPTP is a neurotoxin precursor to MPP+, which induces PD
via inducing oxidative stress in the substantia nigra and
destroying dopaminergic neurons [47]. The therapeutic effect of
CNB-001, a novel pyrazole derivative of CUR, against MPTP
in an experimental method of PD was reported. Application of
CNB-001 (24 mg/kg) improved motor impairment and oxidative
stress and decreased dopamine transporter, vesicular monoamine
transporter 2 (VMAT2) and tyrosine hydroxylase (TH) expres-
sions in mice exposed to MPTP. These data indicated the ther-
apeutic effect of CNB-001 for treatment of PD [48].
3.7. Tetrachlorobenzoquinone (TCBQ)
Tetrachlorobenzoquinone is a combined substance of two
constant pollutants, pentachlorophenol and hexachlorobenzene
[49]. Hexachlorobenzene is used as a fungicide and produced as
the generation of industrial interactions [49]. Pentachlorophenol
is used as an anti-microbial, anti-sapstain, pesticide, biocide
defoliant, wood preservative, and disinfectant agent [50]. It was
observed that TCBQ caused the cytotoxicity in PC12 cells by
induction oxidative stress and inﬂammatory cytokines release.
TCBQ activates nuclear factor-kappa B (NF-kB) signaling and
leads to increase in mRNA and protein expressions of mediators,
and inﬂammatory cytokines such as cyclooxygenase-2 (COX-2),
prostaglandin E2 (PGE2), TNF-a, inducible nitric oxide syn-
theses (iNOS), the production of NO, interleukin-6 (IL-6), and
interleukin-1 beta (IL-1b). CUR could prevent the neurotoxic
effect of TCBQ by reducing inﬂammatory responses and
oxidative stress in PC12 cells [51].
3.8. Pentylenetetrazole (PTZ)
PTZ is an effective drug for circulatory and respiratory stimu-
lant, and depression; however, prevention of its side effects such as
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induce seizures [53]. The therapeutic effect of CUR against PTZ
induced oxidative stress, mitochondrial dysfunctions, and
cognitive defects in a rat model of epilepsy were indicated. CUR
(100 mg/kg, p.o.) injection ameliorated cognitive deﬁcits in PTZ
rats. The current research proposed that CUR treatment could be
able to control cognitive functions via ameliorating mitochondrial
functions and oxidative stress (decreased ROS generation, PO,
lipid peroxidation, and increased GSH activities) [54]. The effect
of CUR on the development of kindling in PTZ kindled rats and
its role in apoptosis and neuronal damage has been also
indicated. CUR (300 mg/kg) elevated the latency to clonic
seizures, myoclonic jerks, generalized tonic-clonic seizures, and
reduced the number of myoclonic jerks and ameliorated the seizure
score. CUR reversed PTZ kindling by apoptosis and ameliorating
oxidative stress [54].
3.9. Sevoﬂurane (SEVO)
SEVO is a highly ﬂuorinated methyl isopropyl ether,
nonﬂammable, sweet-smelling applied as an inhalational
anesthetic for maintenance and induction of general anes-
thesia that is able to cause neurological dysfunctions in the
brain and leads to neuronal damage later in life [50]. It was
reported that CUR prevented the SEVO anesthesia-induced
cognitive defects in mice. CUR improved early memory-
related proteins, inﬂammation, apoptosis, oxidative-
nitrosative stress, and later cognitive dysfunction in animal
exposed to SEVO. This study indicated that CUR prevented
the SEVO exposure-induced cognitive defects later in life via
controlling oxidative nitrosative stress, inﬂammation, and
apoptosis in mice brain [50].
3.10. Sodium nitroprusside (SNP)
SNP, an inorganic compound, is used as a vasodilator drug to
reduce blood pressure by releasing NO [55]. However, many
adverse effects such as brain damage may occur during
treatment with SNP [55]. The therapeutic effects of
Theracurmin (®), and CUR, versus SNP-induced oxidative
damage in cerebrum, has been indicated [56]. Oral treatment of
Theracurmin (®) (1 g/kg and 3 g/kg) mainly ameliorated brain
damage and motor impairment induced by SNP. However,
CUR (300 mg/kg, orally) has no protective effect against
motor dysfunction induced by SNP. This study indicated that
CUR and Theracurmin (®) improved brain damage and motor
impairment via inhibiting oxidative stress. However, Oral
administration of Theracurmin (®), was more effective than
CUR due to its high bioavailability [56].
3.11. Acrylamide (ACR)
ACR with the chemical formula C3H5NO, a vinyl monomer,
is a chemical agent that used in several industrial processes,
including preparing dyes, paper, and plastics, caulk, food
packaging, and some adhesives and in treating drinking water
and wastewater [57]. ACR is seen in cigarette smoke. ACR
formation may occur during food processing with high-
temperature cooking, such as roasting, frying and baking [57].
In this situation, the interaction between sugars and an amino
acid results in acrylamide formation [57]. ACR is a highlytoxic agent that is easily absorbed by the skin and distributed
throughout the body organs. The neurotoxicity of ACR has
also been observed in exposed human and animals [57].
The ameliorative effect of CUR versus ACR-induced oxida-
tive stress in the neuronal cell of Drosophila was reported. CUR
decreased the incidence of ACR-induced mortality, and amelio-
rated the activities of oxidative stress markers, mitochondrial
function in the ﬂy head region. In addition, CUR resorted
acetylcholinesterase and dopamine levels in ﬂy head region [58].
The efﬁcacy of CUR against ACR-induced mitochondrial
dysfunction, neurotoxicity and oxidative stress in an experimental
model has been indicated. CUR (50 mg/kg) signiﬁcantly
ameliorated ACR-induced oxidative stress (reduced levels of
ROS, MDA and NO) and restored the GSH activities and the
levels of brain regions (cortex – Ct, cerebellum – Cb) and anti-
oxidant enzymes in sciatic nerve (SN). CUR decreased ACR-
induced increase in cytosolic calcium activities in cerebellum
and sciatic. In addition, CUR ameliorated acetylcholinesterase
activity and dopamine level in brain regions. Taken together these
indicated that CUR may be therapeutic as effective agents in the
management neuropathy problem induced by ACR [59].
3.12. Streptozotocin (STZ)
Streptozotocin (2-deoxy-2-(3-(methyl-3-nitrosoureido)-D-
glucopyranose)) is produced by Streptomyces achromogenes
and that intracerebro-ventricular (ICV) STZ injection made
Alzheimer's model [60]. Neuroprotective effects of CUR in ICV
injection STZ-induced Alzheimer's model in rodents have been
observed. It was indicated that CUR prevented oxidative stress
and extrinsic apoptosis in ICV-STZ-injected rats. CUR treatment
decreased the hippocampal b-amyloid storage and ameliorated
cognitive disorder in passive avoidance tasks and Morris water
maze. Therefore, ICV-STZ-induced Alzheimer's dementia in-
duces apoptosis in hippocampus, which could be decreased by
treatment of CUR [60].
3.13. Arsenic (As)
As, a natural ingredient of the earth's crust, is greatly divided
in the whole of the environment and it belongs to the heavy
metal group [55]. Its inorganic form is highly toxic. Human faced
to high amount of As occurred via smoking tobacco, industrial
processes, food, drinking contaminated water, and irrigation
[55]. As exposure causes oxidative damage in the tissues
including brain [55]. The protective effects of nanoparticles-
encapsulated CUR (CUR-NP) and CUR versus sodium AS-
induced neuronal oxidative damage in rat has been indicated.
Treatment with CUR and CUR-NP ameliorated increased lipid
peroxidation, GPx, GSH content and the levels of SOD, CAT,
and glutathione reductase (GR) in the brain of rat exposed to As.
The histopathological evaluation also conﬁrmed therapeutic ef-
fects of CUR-NP and CUR. However, CUR-NP acts more
effective than CUR on As-induced oxidative damage brain tis-
sue [61].
3.14. 3-Nitropropionic acid (3-NPA)
3-nitropropionic acid (C3H5NO4) is a mycotoxin that is
generated by a number of fungi and seen in some food and
traditional Chinese medicines [62]. It is a potent mitochondrial
Table 1
Antidotal effects of CUR against neurotoxic agents.
Antidote Toxin Experimental study Mechanism References
CUR GalN Rat Prevention of neurotoxicity by decreasing LPO, PO, and cleaved CASP3
expression, and increasing antioxidant content in the neuronal mitochondria
[36]
FA Rat Prevention of neurotoxicity by decreasing LPO [43]
ROT Rat Prevention of PD via decreasing ROS and MDA levels and increasing the
levels of GSH
[44]
PTZ Rat Prevention of cognitive defects by decreasing ROS generation, LPO and PO
and increasing the levels of GSH
[54]
ACR Rat Prevention of neurotoxicity by decreasing ROS, MDA and NO levels and
increasing the levels of GSH and antioxidant enzymes
[58]
STZ Rat Prevention of AD via modulating apoptosis and OS [60]
As Rat Prevention of neurotoxicity by decreasing LPO levels and increasing the
levels of GSH, SOD, CAT, GPx and GR
[61]
3-NPA Rat Prevention of neurotoxicity by decreasing LPO, NO2 and TNF-a and IL-1b
levels increasing the levels of GSH
[64]
Oxa Rat Prevention of neurotoxicity by OS [63]
F Mice Prevention of neurodegeneration by decreasing LPO in hippocampal regions [42]
SEVO Mice Prevention of cognitive defects via modulating apoptosis, INF, and O & NS [50]
SNP Mice Prevention of neurotoxicity by modulating OS [56]
MPTP PC12 cells Prevention of neurotoxicity by decreasing IL-1b, IL-6, TNF-a, iNOS, COX-2,
NO, PGE2
[48]
CUR-NP As Rat Prevention of neurotoxicity by decreasing LPO levels and increasing the
levels of GSH, SOD, CAT, GPx and GR
[61]
THC VCR Rat Prevention of peripheral neuropathy by decreasing LPO, NO and TNF-a
levels and increasing the levels of GSH, SOD, CAT and GPx
[46]
CNB-001 TCBQ Mice Prevention of PD by modulating OS [51]
AD: Alzheimer's disease; INF: Inﬂammation; NS: Nitrosative stress; OS: Oxidative stress; LPO: Lipid peroxidation.
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signs of Huntington's disease [62]. CUR has been showed to have
therapeutic activity by reducing oxidative stress. The
neuroprotective effect of CUR versus 3-NPA induced neuro-
toxicity in rats has been indicated. Injection of 3-NPA (10 mg/kg
for 21 d) illustrated the biochemical changes [lipid peroxidation,
nitrite (NO2), and GSH level], reduction in body weight and
neuroinﬂammatory factors (TNF-a and IL-1b level), and decli-
nation of motor function and neurochemical (DA, NE, 5-HT,
DOPAC, 5-HIAA and HVA). CUR (25 mg/kg and 50 mg/kg)
administration once daily for 21 d ameliorated these modiﬁca-
tions. This study indicated the therapeutic effect of CUR versus
3-NPA-induced neurotoxicity [62].
3.15. Oxaliplatin (Oxa)
Oxa is a chemotherapy agent and used to treat metastatic
colorectal cancer [63]. However, a serious dose-limiting side
effect such peripheral neurotoxicity is the major concern about
oxaliplatin use in the cure of cancer tissues [63]. It is observed
that its neurotoxicity caused by oxidative stress limits its
therapeutic application in long-term use. The neuroprotective
effects of CUR on respiratory chain complexes in the brain and
Oxa-induced mitochondrial oxidative stress of rats have been
reported. Pretreatment with CUR signiﬁcantly improved pro-
tein carbonyl content induced by Oxa and the mitochondrial
lipid peroxidation levels. CUR improved modiﬁed enzymatic
antioxidants and non-enzymatic and also complex enzymes of
mitochondria. It was suggested that CUR reduced Oxa-induced
side effects in the brain by ameliorating oxidative stress as
document by mitochondrial disorder [63]. Table 1 showed the
protective effects of CUR against agents-induced
neurotoxicity.4. Conclusions
In this study, several animal studies from 2014 to 2015 were
summarized to ﬁnd the protective effects of CUR against tox-
icities agents. According to the results of different studies, CUR
acts as an antidote in neurotoxicity induced by toxic agents.
GalN, F, FA, ROT, MPTP, TCBQ, ACR, STZ, As, 3-NPA, and
Oxa are some examples of chemical agents that CUR could
protect the brain against their toxicity. It is also conﬁrmed CUR
with excessive therapeutic effects, showed protective effects
against some chemical drugs such as VCR, PTZ, SEVO, STNP
which have organ toxicities, particularly in overdose. Different
mechanisms such as inhibition of oxidative stress, inﬂammation
and apoptosis are mentioned in CUR antidotal effects. In
conclusion, CUR has protective effects against toxicities
induced by toxic agents. However, more studies were needed to
verify the antidotal effects of CUR in human intoxications.
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